Clinical Trials Logo

Lipedema clinical trials

View clinical trials related to Lipedema.

Filter by:

NCT ID: NCT03710798 Completed - Obesity, Morbid Clinical Trials

Effect of an Low Carbon High Fat Diet on Pain- and Quality of Life in Patients With Lipedema

LIPODIET
Start date: October 1, 2018
Phase: N/A
Study type: Interventional

Lipedema is a chronic disease with unproportional, symmetrical fat accumulation in the lower extremities. Patients experience pain in affected areas, and reduced quality of life. Today's treatment is physiotherapy and surgery (liposuction). Recent research shows that ketogenic-diet with low carbohydrate, high fat (LCHF) conant can lead to reduced pain, increased quality of life and change in body composition. Goals: Investigate the effect of LCHF diet on pain, quality of life and body composition.

NCT ID: NCT03634462 Completed - Lipedema Clinical Trials

Complete Decongestive Therapy With Negative Pressure for Lipedema and Lymphedema Therapy

Start date: January 15, 2019
Phase: N/A
Study type: Interventional

This study is designed to investigate the therapy outcomes from routine physical therapy in persons with lipedema and secondary limb lymphedema. Complete decongestive therapy (CDT) is a common conservative treatment to optimize lymphatic functioning using exercise, compression, lymphatic stimulation and skin care. PhysioTouch is a gentle graded negative pressure device designed to enhance lymphatic stimulation that is used by the skilled therapist in conjunction with hands on techniques of tissue mobilization for enhanced clearance of lymph stasis in persons with lymphedema. This study will investigate the conservative treatment impact in patients with lipedema and lower extremity lymphedema using this conservative available technique.

NCT ID: NCT03492840 Completed - Lipedema Clinical Trials

Treatment of Women With Lipedema Involving Substantial Fat Knee of Women and Men With Nodular Dercum's Disease

Start date: June 28, 2018
Phase: Phase 2
Study type: Interventional

This is an open label, 2 cohort, clinical trial in women with lipedema with substantial fat above the knee and men with Dercum's disease. Each cohort will have 6 subjects who will receive RZL-012.

NCT ID: NCT02907411 Completed - Lipedema Clinical Trials

Quadrivas Therapy® to Reduce Lipedema Subcutaneous Adipose Tissue (QUADRIVAS)

QUADRIVAS
Start date: September 1, 2016
Phase: N/A
Study type: Interventional

Quad Rivas Therapy has been developed by Alyna Eekma from the Netherlands for over thirteen years; anecdotally she has been able to significantly reduce lipedema SAT in women with Stage 1 and 2 lipedema, and can reduce lipedema SAT by 80% in women with Stage 3 lipedema. The study will last for one month, for a total of 12 treatments per subject, seven subjects total, to see if there is a change in percent body fat percentage over the course of these treatments.